Respiratory distress syndrome in the newborn
dc.contributor.author | Aslan, Mustafa Törehan | |
dc.date.accessioned | 2024-10-29T17:43:50Z | |
dc.date.available | 2024-10-29T17:43:50Z | |
dc.date.issued | 2023 | |
dc.department | Tekirdağ Namık Kemal Üniversitesi | |
dc.description.abstract | Respiratory distress syndrome (RDS) is one of the most common main causes of respiratory failure, especially in very preterm newborns. Atelectasis results from a surfactant deficiency resulting in lung injury due to increased ventilation-perfusion mismatch and a marked pulmonary inflammatory response. The key intervention to prevent RDS, particularly for preterm delivery <34 weeks of gestation, is the administration of antenatal corticosteroid therapy in high-risk pregnant women. Maintaining body temperature after birth, proper ventilation, surfactant treatment, fluid, and perfusion, etc. Optimal treatment management, such as the delivery room, is very important and critical along with appropriate care services. © 2023 Nova Science Publishers, Inc. All rights reserved. | |
dc.identifier.endpage | 181 | |
dc.identifier.isbn | 979-888697714-1 | |
dc.identifier.isbn | 979-888697545-1 | |
dc.identifier.scopus | 2-s2.0-85159920511 | |
dc.identifier.startpage | 169 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/12646 | |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | en | |
dc.publisher | Nova Science Publishers, Inc. | |
dc.relation.ispartof | Current Topics in Perinatology and Neonatology | |
dc.relation.publicationcategory | Kitap Bölümü - Uluslararası | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Neonates | |
dc.subject | Prematurity | |
dc.subject | Respiratory distress syndrome (RDS) | |
dc.subject | Surfactant | |
dc.title | Respiratory distress syndrome in the newborn | |
dc.type | Book Chapter |